Manforce condom maker Mankind Pharma may launch mega Rs 4,20

In 2015, Capital International had purchased an 11 percent stake in Mankind Pharma from ChrysCapital for $200 million. In April 2018, a ChrysCapital-led consortium, which included GIC and CPPIB, made a stunning comeback and bought a 10 percent stake again for around $350 million.

Related Keywords

India , Delhi , Nepal , Emcure Pharma , Cyril Amarchand Mangaldas , Ramesh Juneja , Shardul Amarchand Mangaldas , Macleods Pharma , Sidley Austin , Jp Morgan , Capital International , Mankind Pharma , Panacea Biotec , Gland Pharma , Chrys Capital , Manforce Condoms , Prega News , Bain Capital Backed Emcure Pharma , Mahindra Capital , Axis Capital , Amarchand Mangaldas , Ipo , Launch , Pril , Chryscapital , Dic , Cppib , Condoms , Uhrp ,